REMATIQ, a Berlin, Germany-based AI-driven platform focused on automating product compliance in the medtech sector, has raised €5.4 million in seed funding.  

Investors  

The round was led by Project A Ventures, with participation from Amino Collective, HelloWorld, and prominent business angels, including Boris Lokschin and Timo Fleßner.  

Founded in 2012, Project A Ventures is a venture capital investment firm based in Berlin, Germany, specializing in early-stage companies within the technology industry. The firm provides both capital and operational support to startups.  

REMATIQ Use of Funds

The company will use the funds to develop its AI technology further, expand its engineering team, and drive international growth across Europe and the United States.  

About REMATIQ

Founded in 2023 by David Boutellier and Florian Scherer, REMATIQ provides an AI-powered platform designed to streamline and automate product compliance processes in the MedTech industry. The company uses artificial intelligence to simplify compliance workflows during medical device development. It translates complex regulations—like MDR and FDA—into structured, actionable requirements and integrates them into companies' existing systems. Headquartered in Berlin, Germany, their goal is to bring life-saving innovations to market faster and safer. 

Funding Details  

Company: REMATIQ GmbH  

Raised: €5.4M  

Round: Seed  

Funding Date: April 2025  

Lead Investor: Project A Ventures  

Additional Investors: Amino Collective, HelloWorld, Boris Lokschin, Timo Fleßner  

Company Website: https://rematiq.com/  

Software Category: MedTech Compliance, Regulatory Technology  

Source: REMATIQ Press Release